Intratio
Loading...
Skip to main content
Model output · Signal date 2026-10-13

Envoy Medical, Inc. (COCH) Stock Forecast Oct. 13, 2026

Analysis updated on Oct. 13, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq

Follow Unlock full AI forecasts
Rating · 90D Neutral Alpha
90-day forecast Sign up free to reveal
30-day forecast Alpha
Rank in coverage Middle 30% of 5379 stocks scored
Rank correlation · 90D n/a No per-ticker sample yet
Market Cap $50M small-cap · #17 of 24 peers
Summary

Envoy Medical, Inc. (COCH) stock forecast summary

On Oct. 13, 2026, COCH is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5379 stocks scored that day.

Envoy Medical, Inc. is a small-cap company with a market capitalization of $50M. It ranks number 17 by market capitalization among the 24 Orthopedic, Prosthetic & Surgical Appliances & Supplies issuers in our coverage with a current forecast. Its Gross Margin of -298.9% is the lowest of the 20 peers that report one.

A per-ticker accuracy statistic for COCH is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)

A free account shows the exact forecast, rating and rank of 3 tickers you follow, COCH included.

Follow COCH free
Price

COCH price chart and AI forecast

COCH
Cross-section · 2026-10-13

How COCH ranks among 5379 stocks

90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Fundamentals

Envoy Medical, Inc. (COCH) fundamentals

Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Orthopedic, Prosthetic & Surgical Appliances & Supplies peers listed below that report each metric.

Reported net income does not reconcile with earnings per share and the share count, so net-income-based ratios are withheld.

Valuation & Market

MetricCOCHIndustry medianRank
Market Cap $50M $132M 17/24
EPS $-0.98 – –
Revenue/Share $0.00 – –

Profitability & Margins

MetricCOCHIndustry medianRank
Gross Margin -298.9% 50.1% 20/20
Operating Margin -8846.8% -8.7% 21/21
EBT Margin -9403.4% -19.3% 21/21

Financial Health

MetricCOCHIndustry medianRank
Current Ratio 1.73x 2.55x 20/24
Quick Ratio 1.61x 2.01x 13/21
Interest Coverage -928.2x -3.4x 19/21
Working Capital $9M $71M 16/22

Cash Flow

MetricCOCHIndustry medianRank
Operating Cash Flow -$22M -$680K 19/22

Operational Efficiency

MetricCOCHIndustry medianRank
Asset Turnover 0.02x 0.72x 17/18
Receivables Turnover 4.2x 5.5x 12/16
Inventory Turnover 0.6x 2.1x 20/21
Fixed Assets Turnover 0.2x 6.2x 18/18
Days Sales Outstanding 86 days 67 days 5/16
Days Inventory 573 days 177 days 2/21
Payables Period 739 days 53 days 3/18
Cash Conversion Cycle -79 days 140 days 13/15

Income Statement

MetricCOCHIndustry medianRank
Total Revenue $0.00M $150M 18/18
Operating Income -$23M -$6M 18/22
R&D Expense $14M $19M 11/19
SG&A Expense $10M $80M 17/19
Cost of Goods Sold $1M $55M 18/20

Dividend & Shareholder Information

MetricCOCHIndustry medianRank
Shares Outstanding 77M – –

Balance Sheet Highlights (USD millions)

Total Current Assets$22M
Cash & Short-term Investments$20M
Accounts Receivable$50K
Inventory$2M
Total Liabilities$20M
Short-term Debt$11M
Quarterly Financial Reports

COCH quarterly financials and insider trading

Industry Peers · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Envoy Medical, Inc. (COCH) industry peers

Companies classified under the same SEC industry code as Envoy Medical, Inc. (Orthopedic, Prosthetic & Surgical Appliances & Supplies): 27 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.

Reveal all forecasts · See exact % predictions for all competitors

Sign up free
Company 90-Day AI Forecast (Alpha) Market Cap P/E Ratio P/B Ratio
COCH Envoy Medical, Inc. ▶ $50M – –
ISRG Intuitive Surgical Inc ▼ $149.10B 47.5x 8.2x
SNN Smith & Nephew Plc ▼ $24.29B – –
STE Steris Plc ▼ $21.35B 26.5x 3.0x
ZBH Zimmer Biomet Holdings, Inc. ▼ $17.58B 21.8x 1.4x
ALGN Align Technology Inc ▼ $10.20B 24.7x 2.4x
MSA Msa Safety Inc ▼ $7.01B 22.3x 5.0x
ESTA Establishment Labs Holdings Inc. ▲ $1.74B – 80.6x
CDRE Cadre Holdings, Inc. ▶ $1.12B 31.1x 3.2x
ENOV Enovis Corp ▶ $1.10B – 0.7x
AVR Anteris Technologies Global Corp. ▼ $629M – 2.5x
SMTI Sanara Medtech Inc. ▼ $323M – 40.7x
INGN Inogen Inc ▶ $168M – 1.0x
LAKE Lakeland Industries Inc ▲ $97M – 0.8x
NTRB Nutriband Inc. ▲ $71M – 13.3x
APT Alpha Pro Tech Ltd ▲ $59M 13.9x 0.9x
MYO Myomo, Inc. ▲ $51M – 8.8x
MLSS Milestone Scientific Inc. ▲ $31M – 8.9x
LFWD Lifeward Ltd. ▲ $18M – 1.4x
UEEC United Health Products, Inc. ▶ $12M – –
RGNT Regentis Biomaterials Ltd. ▼ $8M – 4.4x
CLGN Collplant Biotechnologies Ltd ▶ $5M – 0.9x
RBOT Vicarious Surgical Inc. ▼ $360K – –
FEED Envue Medical, Inc. ▼ $320K – –
BBLG Bone Biologics Corp ▶ N/A – –
CUPR Cuprina Holdings (Cayman) Ltd ▼ N/A – –
LGMK Logicmark, Inc. ▼ N/A – –

Where COCH sits on the market map

Industrial Applications and Services · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Explore the map →
News

Envoy Medical, Inc. (COCH) stock news

Loading...

FAQ

Envoy Medical, Inc. (COCH) stock forecast FAQ

What is the Envoy Medical, Inc. (COCH) stock forecast?

On Oct. 13, 2026, COCH is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5379 stocks scored that day.

How accurate are Envoy Medical, Inc. stock predictions?

A per-ticker accuracy statistic for COCH is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are Envoy Medical, Inc. forecasts updated?

Envoy Medical, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.

Which companies are Envoy Medical, Inc.'s industry peers?

27 issuers in our coverage, COCH included, share the SEC industry code Orthopedic, Prosthetic & Surgical Appliances & Supplies. The largest are: Intuitive Surgical Inc (ISRG), Smith & Nephew Plc (SNN), Steris Plc (STE), Zimmer Biomet Holdings, Inc. (ZBH), Align Technology Inc (ALGN), Msa Safety Inc (MSA).

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.